The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of axitinib plus pembrolizumab for patients with advanced alveolar soft part sarcoma (ASPS) and other soft tissue sarcomas (STS).
 
Breelyn A. Wilky
Consulting or Advisory Role - Janssen Oncology; Lilly; Novartis
Research Funding - Agenus; ArQule; Daiichi Sankyo; Merck Sharp & Dohme; Novartis
Travel, Accommodations, Expenses - Advenchen Laboratories; Lilly; Novartis
 
Matteo Maria Trucco
No Relationships to Disclose
 
Despina Kolonias
No Relationships to Disclose
 
Eric Wieder
No Relationships to Disclose
 
Ty Subhawong
Employment - HCA Healthcare (I)
Stock and Other Ownership Interests - HCA Healthcare (I)
 
Andrew Rosenberg
No Relationships to Disclose
 
Deukwoo Kwon
No Relationships to Disclose
 
Wungki Park
No Relationships to Disclose
 
Vaia Florou
No Relationships to Disclose
 
Darcy A Kerr
No Relationships to Disclose
 
Efrosyni Sfakianaki
No Relationships to Disclose
 
Jaime R. Merchan
Consulting or Advisory Role - Exelixis
Research Funding - Astellas Oncology; Eisai; Genentech; Halozyme; Lilly; Novartis; Peloton Therapeutics; Rexahn Pharmaceuticals; Viralytics; Vyriad
 
Krishna Komanduri
No Relationships to Disclose
 
Jonathan C. Trent
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - Janssen; Lilly; Novartis